Back
Fortinet, Inc. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Sell
44
FTNT
Fortinet, Inc.
Last Price:
$82.22
Seasonality Move:
14.31%
Sell
48
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$36.24
Seasonality Move:
6.21%
Sell
44
Fortinet, Inc. (FTNT)
is a Sell
Is Fortinet, Inc. a Buy, Sell or Hold?
-
The current Fortinet, Inc. [FTNT] share price is $82.22. The Score for FTNT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
FTNT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $36.23. The Score for RARE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FTNT Stock Price Chart
What is Fortinet, Inc.'s stock price today?
-
The Fortinet, Inc. share price today is $82.22Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FTNT is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $36.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.
FTNT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 48.66 | Sell |
| Chaikin Money Flow: | 538160 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (80.02 - 83.76) | Buy |
| Bollinger Bands (100): | (77.28 - 90.32) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.99 | Buy |
| Relative Strength Index (14 RSI): | 61.17 | Buy |
| Chaikin Money Flow: | -31475 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.18 - 35.78) | Buy |
| Bollinger Bands (100): | (28.77 - 33.95) | Buy |
FTNT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 83.52 | Sell |
| 20-day SMA: | 81.81 | Buy |
| 50-day SMA: | 83.35 | Sell |
| 200-day SMA: | 92.51 | Sell |
| 8-day EMA: | 82.76 | Sell |
| 20-day EMA: | 82.58 | Sell |
| 50-day EMA: | 83.18 | Sell |
| 200-day EMA: | 87.95 | Sell |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.32 | Sell |
| 20-day SMA: | 34.36 | Buy |
| 50-day SMA: | 33.41 | Buy |
| 200-day SMA: | 33.75 | Buy |
| 8-day EMA: | 35.88 | Buy |
| 20-day EMA: | 34.85 | Buy |
| 50-day EMA: | 33.54 | Buy |
| 200-day EMA: | 34.8 | Buy |
Fortinet, Inc. Earnings Growth & FTNT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.23 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
Fortinet, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||